These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 25749918

  • 21. Transcatheter closure of the patent ductus arteriosus at a public sector hospital in Soweto, South Africa: a review of patient outcomes over 15 years.
    Adams PE, Chersich MF, Cilliers A.
    Cardiovasc J Afr; 2018; 29(4):246-251. PubMed ID: 30204220
    [Abstract] [Full Text] [Related]

  • 22. Transcatheter device closure of patent ductus arteriosus.
    Sultan M, Ullah M, Sadiq N, Akhtar K, Akbar H.
    J Coll Physicians Surg Pak; 2014 Oct; 24(10):710-3. PubMed ID: 25327911
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Closure of patent ductus arteriosus in children, small infants, and premature babies with Amplatzer duct occluder II additional sizes: multicenter study.
    Sungur M, Karakurt C, Ozbarlas N, Baspinar O.
    Catheter Cardiovasc Interv; 2013 Aug 01; 82(2):245-52. PubMed ID: 23460349
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Percutaneous closure of patent ductus arteriosus in children using amplatzer duct occluder II: relationship between PDA type and risk of device protrusion into the descending aorta.
    Masri S, El Rassi I, Arabi M, Tabbakh A, Bitar F.
    Catheter Cardiovasc Interv; 2015 Aug 01; 86(2):E66-72. PubMed ID: 26032159
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Lung perfusion studies after transcatheter closure of persistent ductus arteriosus with the Amplatzer duct occluder.
    Polat TB, Celebi A, Hacımahmutoglu S, Akdeniz C, Erdem A, Fırat F.
    Catheter Cardiovasc Interv; 2010 Sep 01; 76(3):418-24. PubMed ID: 20839357
    [Abstract] [Full Text] [Related]

  • 36. Short-Term Outcomes of Patent Ductus Arteriosus Closure With New Occlutech® Duct Occluder: A Multicenter Study.
    Dedeoglu R, Bilici M, Demir F, Demir F, Acar OÇ, Hallioglu O, Pac A, Kiziltas A, Karabel D, Kula S, Cimen D, Baspinar O, Atik SU, Saltik IL.
    J Interv Cardiol; 2016 Jun 01; 29(3):325-31. PubMed ID: 27090770
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Use of the amplatzer vascular plug II device to occlude different types of patent ductus arteriosus in pediatric patients.
    Garay FJ, Aguirre D, Cárdenas L, Springmuller D, Heusser F.
    J Interv Cardiol; 2015 Apr 01; 28(2):198-204. PubMed ID: 25832322
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.